Canada markets closed

Interpace Biosciences, Inc. (IDXG)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
1.41000.0000 (0.00%)
At close: 03:58PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 6.17M
Enterprise Value 13.86M
Trailing P/E 5.64
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)0.15
Price/Book (mrq)10.04
Enterprise Value/Revenue 0.34
Enterprise Value/EBITDA 3.71

Trading Information

Stock Price History

Beta (5Y Monthly) 0.67
52-Week Change 341.00%
S&P500 52-Week Change 322.38%
52 Week High 33.5400
52 Week Low 30.7650
50-Day Moving Average 31.4431
200-Day Moving Average 31.2039

Share Statistics

Avg Vol (3 month) 36.01k
Avg Vol (10 day) 34.17k
Shares Outstanding 54.38M
Implied Shares Outstanding 64.72M
Float 83.35M
% Held by Insiders 126.24%
% Held by Institutions 10.00%
Shares Short (Feb 12, 2021) 447.35k
Short Ratio (Feb 12, 2021) 40.19
Short % of Float (Feb 12, 2021) 41.18%
Short % of Shares Outstanding (Feb 12, 2021) 41.17%
Shares Short (prior month Jan 15, 2021) 468.56k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Jan 15, 2020
Ex-Dividend Date 4N/A
Last Split Factor 21:10
Last Split Date 3Jan 15, 2020

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 1.99%
Operating Margin (ttm)12.84%

Management Effectiveness

Return on Assets (ttm)12.12%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)40.21M
Revenue Per Share (ttm)9.31
Quarterly Revenue Growth (yoy)23.40%
Gross Profit (ttm)N/A
EBITDA 3.84M
Net Income Avi to Common (ttm)1.11M
Diluted EPS (ttm)0.2500
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)3.5M
Total Cash Per Share (mrq)0.8
Total Debt (mrq)11.19M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.59
Book Value Per Share (mrq)-14.17

Cash Flow Statement

Operating Cash Flow (ttm)3.79M
Levered Free Cash Flow (ttm)4.22M